Radiotherapy for brain metastases: Defining palliative response

Radiotherapy and Oncology

Volumn 61, Issue 1, 2001, Pages 71-76

  Bezjak, Andrea ^a   Adam, Janice ^a   Panzarella, Tony ^b   Levin, Wilfred ^a   Barton, Rachael ^a   Kirkbride, Peter ^a   McLean, Michael ^a   Mason, Warren ^b   Wong, Chong Shun ^a   Laperriere, Normand ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brain metastasis; Palliation; Radiotherapy

Indexed keywords

DEXAMETHASONE; STEROID;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PERFORMANCE; PRIORITY JOURNAL; RADIATION RESPONSE; SCORING SYSTEM; STEROID THERAPY; SYMPTOM; TREATMENT OUTCOME; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PALLIATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0034812938     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(01)00426-1     Document Type: Article

References (26)

1. Symptom response following radiotherapy for brain metastases
2. The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group
3. A confidence interval for the median survival time
4. Roentgen-ray therapy of cerebral metastases
5. Value of radiation therapy in the management of intracranial metastases
6. Fractionation schedules in radiation treatment of cerebral metastases
7. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 Gray and greater
8. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials
9. Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases
10. The influence of extent and local management on the outcome of radiotherapy for brain metastases
11. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases
12. Response criteria for phase II studies of supratentorial malignant glioma
13. Reporting results of cancer treatment
14. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis
15. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the Radiation Therapy Oncology Group (RTOG) 9104
16. Accelerated radiotherapy for brain metastases
17. Improvement in quality of survival following whole-brain irradiation for brain metastases
18. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires
19. A randomized trial of surgery in the treatment of single metastases to the brain
20. Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study
21. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases
22. Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer
23. Evaluating the quality of life of cancer patients: Assessments by patients, significant others, physicians and nurses
24. The objective response of brain metastases on radiotherapy: A prospective study using computer tomography
25. The Functional assessment of cancer therapy (FACT) Scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumours